2.7
갑상선종은 갑상선이 비정상적으로 커진 상태를 말하며, 이는 확산성 갑상선(균일한 비대) 또는 결절형(단일 또는 여러 결절)으로 나타날 수 있습니다. 기능적으로는 무독성(정상/저호르몬 수치) 또는 독성(과도한 호르몬 생성)으로 분류됩니다.
병태생리
확산성 갑상선 비대는 일반…
갑상선종은 갑상선의 비정상적으로 비대한 비정상 비대입니다. 이는 확산되고 균일한 부기로 나타나거나, 하나 이상의 결절이 있는 결절 형태로 나타날 수 있습니다.
확산성 갑상선종은 종종 갑상선 조직의 만성 자극으로 인해 발생하며, 이는 TSH 수치 상승, 면역 매개 활성화 또는 요오드 결핍으로 인해 발생할 수 있습니다.
그레이브스병과 같은 갑상선 항진증에서는 갑상선 자극 면역글로불린이라는 자가항체가 TSH 수용체에 결합하여 과도한 호르몬 생성을 촉진합니다.
갑상선기능저하증에서는 하시모토 갑상선염에서 볼 수 있는 자가면역 파괴나 리튬과 같은 특정 약물로 인해 TSH 만성 상승이 발생할 수 있습니다.
갑상선 호르몬 합성에 영향을 미치는 유전적 결함도 선천성 갑상선종을 유발할 수 있습니다.
장기간 자극을 받으면 확산성 갑상선종은 점차 결절이 될 수 있으며, 결국 자율 호르몬 생성이 발달하여 독성 다결절성 갑상선종이 형성될 수 있습니다. 갑상선종이 커지면서 인접한 구조에 질량을 가해 호흡 곤란이나 삼키기 어려움을 초래할 수 있습니다.
View the full transcript and gain access to JoVE Core videos
Q1: What causes diffuse goiter to develop?
Diffuse goiter results from prolonged thyroid stimulation, commonly due to elevated TSH levels, immune-mediated activation, or iodine deficiency. In hypothyroid conditions like Hashimoto's thyroiditis, chronic TSH elevation drives thyroid enlargement. Conversely, in hyperthyroid conditions such as Graves' disease, thyroid-stimulating immunoglobulins directly stimulate the gland, causing diffuse enlargement despite normal or low TSH levels.
Q2: How does iodine deficiency lead to goiter?
Iodine is essential for thyroid hormone synthesis. When daily intake falls below 100 micrograms, hormone production becomes impaired. The pituitary responds by increasing TSH secretion to compensate, stimulating thyroid tissue growth. Severe deficiency below 10 micrograms per day dramatically elevates TSH levels, causing significant thyroid hypertrophy and visible goiter enlargement.
Q3: What are goitrogens and how do they affect the thyroid?
Goitrogens are substances that interfere with thyroid hormone synthesis. Dietary sources include cabbage, cassava, and turnips, while environmental agents include perchlorate and thiocyanate. Medications such as lithium, propylthiouracil, and methimazole also act as goitrogens. Despite goitrogen exposure, individuals often remain euthyroid because compensatory TSH elevation maintains adequate hormone production.
Q4: How can diffuse goiter progress to toxic multinodular goiter?
Over prolonged stimulation, diffuse goiter may gradually become nodular as thyroid tissue develops heterogeneous growth patterns. Some nodules eventually acquire autonomous hormone production independent of TSH control. This progression, especially in older individuals and sometimes triggered by increased iodine intake, results in toxic multinodular goiter, where nodules produce excess thyroid hormones.
Q5: What compressive symptoms can large goiters cause?
As goiters enlarge, they exert mass effect on adjacent structures. Tracheal compression causes respiratory difficulty and breathing problems. Esophageal compression leads to dysphagia or trouble swallowing. Venous compression can cause facial flushing and neck vein distension. Pemberton's sign—facial flushing and venous engorgement upon arm elevation—indicates superior vena cava compression from a large goiter.
Q6: What is the difference between nontoxic and toxic goiter?
Nontoxic goiter involves thyroid enlargement with normal or low hormone levels, often resulting from iodine deficiency or goitrogen exposure. Toxic goiter produces excess thyroid hormones, as seen in Graves' disease or toxic multinodular goiter. Both types can appear diffuse or nodular, but functional classification depends on whether the enlarged gland produces abnormal hormone levels.
Q7: How do genetic defects contribute to congenital goiter?
Genetic defects affecting thyroid hormone synthesis enzymes can impair the production of thyroid hormones from birth. The fetal pituitary responds by elevating TSH levels to compensate for inadequate hormone production. This chronic fetal TSH stimulation drives thyroid tissue growth in utero, resulting in congenital goiter that is typically associated with hypothyroidism ii pathophysiology complications.